Table 3.

Intention-to-treat analyses assessing the effects of the exercise intervention on cancer-related fatigue, depressive symptoms, health-related quality of life, and life satisfaction in female breast cancer survivors

Change from baseline at week 12	Intervention		Mean difference in the change from baseline to week 12 (95%CI)	Effect size (Cohen’s d)	P
	Exercise (n = 32)	Control (n = 28)
	Mean change (SE)	Mean change (SE)
Cancer-related fatigue, FACT-F, 0–52	1.8 (1.0)	1.4 (1.1)	0.4 (− 2.7 to 3.5)	0.07	0.802
CES-D total score, 0–60	− 2.4 (1.4)	0.0 (1.5)	− 2.4 (− 6.4 to 1.6)	0.30	0.235
FACT-B
PWB subscale, 0–28	1.5 (0.6)	0.8 (0.6)	0.7 (− 0.9 to 2.4)	0.21	0.374
SWB subscale, 0–28	− 1.9 (0.6)	− 0.5 (0.7)	− 1.4 (− 3.2 to 0.5)	0.40	0.143
EWB subscale, 0–24	0.6 (0.4)	0.1 (0.4)	0.5 (− 0.7 to 1.7)	0.23	0.423
FWB subscale, 0–28	− 0.3 (0.5)	0.0 (0.5)	− 0.3 (− 1.8 to 1.2)	0.11	0.647
BCS subscale, 0–40	0.5 (0.7)	2.0 (0.7)	− 1.5 (− 3.4 to 0.4)	0.39	0.116
FACT-B total score, 0–148	0.0 (1.7)	2.9 (1.8)	− 2.9 (− 7.0 to 2.1)	0.30	0.245
SWLS, 0–25	0.0 (0.4)	− 0.6 (0.5)	0.6 (− 0.7 to 1.9)	0.25	0.344

SE standard error, CI confidence interval, FACT-F Functional Assessment of Cancer Therapy-Fatigue, CES-D Center for Epidemiologic Studies-Depression Scale, FACT-B Functional Assessment of Cancer Therapy-Breast, PWB physical well-being, SWB social well-being, EWB emotional well-being, FWB functional well-being, BS breast cancer, SWLS Satisfaction with Life Scale